410 related articles for article (PubMed ID: 31520356)
1. Drosophila as a Model for Tumor-Induced Organ Wasting.
Saavedra P; Perrimon N
Adv Exp Med Biol; 2019; 1167():191-205. PubMed ID: 31520356
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia: lessons from Drosophila.
Liu Y; Saavedra P; Perrimon N
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 35319749
[TBL] [Abstract][Full Text] [Related]
3. Nonmuscle Tissues Contribution to Cancer Cachexia.
Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
Mediators Inflamm; 2015; 2015():182872. PubMed ID: 26523094
[TBL] [Abstract][Full Text] [Related]
4. Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting.
Figueroa-Clarevega A; Bilder D
Dev Cell; 2015 Apr; 33(1):47-55. PubMed ID: 25850672
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
[TBL] [Abstract][Full Text] [Related]
6. CACHEXIA & BROWN FAT: A BURNING ISSUE IN CANCER.
Kir S; Spiegelman BM
Trends Cancer; 2016 Sep; 2(9):461-463. PubMed ID: 28459108
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
8. Cancer cachexia is defined by an ongoing loss of skeletal muscle mass.
Baracos VE; Mazurak VC; Bhullar AS
Ann Palliat Med; 2019 Jan; 8(1):3-12. PubMed ID: 30685982
[TBL] [Abstract][Full Text] [Related]
9.
Hodgson JA; Parvy JP; Yu Y; Vidal M; Cordero JB
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361081
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia: molecular mechanisms and treatment strategies.
Setiawan T; Sari IN; Wijaya YT; Julianto NM; Muhammad JA; Lee H; Chae JH; Kwon HY
J Hematol Oncol; 2023 May; 16(1):54. PubMed ID: 37217930
[TBL] [Abstract][Full Text] [Related]
11. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies.
Martin A; Freyssenet D
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):252-273. PubMed ID: 33783983
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived MMPs regulate cachexia in a Drosophila cancer model.
Lodge W; Zavortink M; Golenkina S; Froldi F; Dark C; Cheung S; Parker BL; Blazev R; Bakopoulos D; Christie EL; Wimmer VC; Duckworth BC; Richardson HE; Cheng LY
Dev Cell; 2021 Sep; 56(18):2664-2680.e6. PubMed ID: 34473940
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.
Jourdain M; Melly S; Summermatter S; Hatakeyama S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2415-2420. PubMed ID: 29969629
[TBL] [Abstract][Full Text] [Related]
15. Host autophagy mediates organ wasting and nutrient mobilization for tumor growth.
Khezri R; Holland P; Schoborg TA; Abramovich I; Takáts S; Dillard C; Jain A; O'Farrell F; Schultz SW; Hagopian WM; Quintana EM; Ng R; Katheder NS; Rahman MM; Teles Reis JG; Brech A; Jasper H; Rusan NM; Jahren AH; Gottlieb E; Rusten TE
EMBO J; 2021 Sep; 40(18):e107336. PubMed ID: 34309071
[TBL] [Abstract][Full Text] [Related]
16. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
17. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
18. The Role of Natural Products in the Improvement of Cancer-Associated Cachexia.
Han Y; Kim HI; Park J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240117
[TBL] [Abstract][Full Text] [Related]
19. STAT3 in the systemic inflammation of cancer cachexia.
Zimmers TA; Fishel ML; Bonetto A
Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]